Sinusoidal cell-derived scores capture biologically relevant pathways of CLD progression and regression and can be measured from existing biopsy material available in most centers worldwide. Despite their retrospective derivation, these scores hold strong promise for prospective validation and clinical implementation as tools for patient stratification, monitoring, and therapeutic guidance.
Guixé-Muntet et al. (Sat,) studied this question.